Diabetes Management

Managing diabetes well is about more than reaching target numbers. It requires time, partnership, and a clinician who understands the full metabolic picture. Diabetes care with Michaela King Klose is intentionally designed for patients who want a higher level of support. Each visit is personal, thorough, and focused on helping you feel better, live stronger, and regain confident control of your health.

For patients with advanced or complex diabetes, Michaela maintains close collaborative relationships with endocrinologists and nephrologists within the Baylor, UTSW, and Methodist systems. This ensures your care remains seamless, coordinated, and deeply personalized.

Using advanced diagnostics, thoughtful education, and a truly individualized treatment plan, Michaela helps you make meaningful improvements not only in your numbers but in your energy, stability, and day-to-day life.

Diabetes is a complex metabolic condition that affects far more than blood sugar. Effective management requires time, precision, education, and a clinician who understands how hormones, nutrition, sleep, stress, inflammation, and cardiovascular risk all work together. Each visit with Michaela is intentionally unrushed, allowing space to assess your patterns, your goals, and your full metabolic picture.

Every evaluation begins with a comprehensive review of blood glucose trends, A1C, lipid markers, kidney function, thyroid balance, body composition, and inflammation. When appropriate, Michaela incorporates advanced cardiometabolic testing such as fasting insulin, ApoB, Lp(a), hsCRP, adiponectin, and Cleveland Heart Lab markers to clarify long-term risk and individualize your treatment plan.

Your care plan may include refined nutrition strategies, targeted supplementation, structured movement guidance, and medication therapy tailored to your unique needs. Michaela prescribes only FDA-approved medications for diabetes management, including metformin, SGLT2 inhibitors such as Jardiance, GLP-1 receptor agonists such as Ozempic, and dual-pathway medications such as Mounjaro when clinically appropriate. She does not prescribe compounded GLP-1 medications. Safety, regulation, and long-term effectiveness always guide treatment decisions.

Follow-up appointments are intentionally longer—typically 30 to 60 minutes—allowing time to review your labs, adjust medications, evaluate glucose patterns, and strengthen lifestyle strategies. For patients with more complex or fluctuating diabetes, Michaela provides closer monitoring and structured communication between visits to prevent complications and promote stability.

When specialized care is needed, Michaela collaborates directly with endocrinologists, nephrologists, and cardiometabolic specialists at Baylor, UTSW, and Methodist. This ensures seamless, coordinated care without duplication of work or gaps in communication.

The goal is not only improved lab results but a meaningful transformation in daily life: steadier energy, better sleep, fewer fluctuations, improved weight and cardiovascular markers, and a renewed sense of confidence in managing your health. Many patients experience rapid and measurable improvements in A1C once they receive consistent, personalized, relationship-centered support.